SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech for less than cash value
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (633)1/8/2022 7:35:57 PM
From: bmaz0011 Recommendation

Recommended By
scaram(o)uche

   of 684
 
LVTX expects to release P1 data for LAVA-051 (MM, AML, CLL) in 1H 2022. They also plan to file an IND for LAVA-1223 (solid tumors) in late 2022. At one point they were guiding to release P1 data for LAVA-1207 (mCRPC) in late 2022 but I'm not sure about that now.

And there's this: JNJ deal
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News